Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 8 reviews

538%
425%
338%
20%
10%
Ask AI

Ask AI about Dinaqor ag

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Dinaqor ag

DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure. Its lead preclinical program, DiNA-001, is focused on the treatment of MYBPC3-linked cardiomyopathy.

DiNAQOR was founded in 2019 and is headquartered in Pfäffikon, Switzerland.

Categories
Biotechnology